Mizuho analyst Ann Hynes raised the firm’s price target on CVS Health (CVS) to $88 from $76 and keeps an Outperform rating on the shares. The firm adjusted price targets in the healthcare facility and managed care space following an analysis of Medicare Advantage star ratings. The target changes are driven by increased earnings visibility on key issues along with the overall rotation into the healthcare sector, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- Amazon (AMZN) Pharmacy Brings Prescription Kiosks to Doctors’ Offices
- CVS Health price target raised to $103 from $84 at Wells Fargo
- Looking for Exposure to UnitedHealth Stock (UNH)? Here’s How to Buy Without the Risk
- Sector Spotlight: UnitedHealth shareholder proposes split of CEO, chair role
- Trump Trade: White House announces drug pricing deal with Pfizer